Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Minimally Invasive Devices

Request full access

Develops medical devices to assist medical professionals during surgery

Cupertino, United StatesFounded 2006Health Tech & Medtech

About Minimally Invasive Devices

Minimally Invasive Devices, Inc. (MID) provides a solution to the common problem of visual impairment during laparoscopic surgery. The company was founded in Columbus, Ohio, in 2007 by Dr. Wayne Poll, a urological surgeon with 22 years of experience in laparoscopic and robotic surgery. Dr. Poll's frustration with frequently having to interrupt procedures to clean the laparoscope lens—a process that could happen up to ten times an hour—drove him to invent a solution. After winning a business plan competition at Ohio State University's Fisher College of Business, he secured initial funding and launched the company.

The core business of Minimally Invasive Devices is the development and sale of the FloShield® family of products to hospitals and ambulatory surgery centers. The business model centers on selling these single-use medical devices directly and through distributors. FloShield addresses the challenge of maintaining a clear view during surgery by preventing fog, smoke, and debris from obscuring the laparoscope lens. The system works by creating a protective CO2 gas barrier, termed Vortex Barrier Technology™, at the tip of the scope. This significantly reduces or even eliminates the need for surgeons to remove the instrument for manual cleaning, which helps to maintain the flow of the procedure and potentially reduce surgical time.

The FloShield product line includes several versions compatible with both traditional and robotic-assisted surgical systems. The main product, FloShield Air, actively defogs the lens. A more advanced version, FloShield Plus, incorporates Flo-X, a biocompatible surfactant solution that allows surgeons to flush and clean the lens inside the patient's body if necessary. The company received FDA 510(k) approval for the FloShield system in 2008 and the CE Mark for European Union sales in 2011. Through a series of funding rounds, MID raised over $30 million to support commercialization, expand its sales force, and continue product development.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2006
Headquarters
Cupertino, United States
Employees
3
Open positions
None listed
Dealroom signal
56.5/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Medical & Healthcare, Surgery, Non-Invasive medical devices and treatments, Tech for Hospitals and Clinics, DT and LS, science-based
Technology
Deep Tech
Business model
Manufacturing
Client focus
B2B

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES C✓Equity / VC Nov 2015 $14M $56M Radius Ventures · Canaan —
GROWTH EQUITY VCEquity / VC Feb 2015 $0 — Undisclosed —
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

Minimally Invasive Devices website traffic

Latest recorded traffic for Minimally Invasive Devices is 90 monthly website visits. Minimally Invasive Devices's team grew 0% over the past year.

Latest monthly visits90 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Minimally Invasive Devices in the Cupertino ecosystem

Live from Dealroom

The Minimally Invasive Devices office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

7 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A5 investors entered at this stage

  • Rev1 Ventures
  • North Coast Ventures
  • Radius Ventures
  • Charter Life Sciences
  • Canaan Partners Israel

Series B and later1 investor entered at this stage

Other known investors1 additional known investor

  • NCT Ventures
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 2 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇺🇸 United States · Cupertino HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Minimally Invasive Devices on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Minimally Invasive Devices’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.